Published in J Virol on February 18, 2009
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
Identification of an intracellular site of prion conversion. PLoS Pathog (2009) 1.61
The role of glycophosphatidylinositol anchor in the amplification of the scrapie isoform of prion protein in vitro. FEBS Lett (2009) 1.04
Prions and the potential transmissibility of protein misfolding diseases. Annu Rev Microbiol (2013) 1.04
Microvesicles/exosomes as potential novel biomarkers of metabolic diseases. Diabetes Metab Syndr Obes (2012) 1.01
Propagation of RML prions in mice expressing PrP devoid of GPI anchor leads to formation of a novel, stable prion strain. PLoS Pathog (2012) 0.98
Cellular aspects of prion replication in vitro. Viruses (2013) 0.95
Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One (2013) 0.90
Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation. J Biol Chem (2011) 0.89
GPI anchoring facilitates propagation and spread of misfolded Sup35 aggregates in mammalian cells. EMBO J (2010) 0.89
Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation. J Biol Chem (2015) 0.88
Prion propagation in cells expressing PrP glycosylation mutants. J Virol (2011) 0.88
Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein. J Virol (2011) 0.85
The role of the prion protein membrane anchor in prion infection. Prion (2009) 0.84
Detection of the GPI-anchorless prion protein fragment PrP226* in human brain. BMC Neurol (2013) 0.81
A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner. J Virol (2013) 0.79
Increased infectivity of anchorless mouse scrapie prions in transgenic mice overexpressing human prion protein. J Virol (2015) 0.79
Shedding light on prion disease. Prion (2015) 0.79
PrP knockout cells expressing transmembrane PrP resist prion infection. J Virol (2016) 0.76
The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation. Prion (2011) 0.76
Prions: Beyond a Single Protein. Clin Microbiol Rev (2016) 0.75
An in vitro approach to identify the key amino acids in the low susceptibility of rabbit PrP to misfolding. J Virol (2017) 0.75
An antipsychotic drug exerts anti-prion effects by altering the localization of the cellular prion protein. PLoS One (2017) 0.75
Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell (1983) 25.46
A new variant of Creutzfeldt-Jakob disease in the UK. Lancet (1996) 20.15
Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell (1992) 17.81
Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol Cell Biol (1986) 16.65
Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature (1997) 15.73
The same prion strain causes vCJD and BSE. Nature (1997) 12.49
Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol (1987) 7.05
In vitro generation of infectious scrapie prions. Cell (2005) 6.86
Cell-free formation of protease-resistant prion protein. Nature (1994) 6.07
Formation of native prions from minimal components in vitro. Proc Natl Acad Sci U S A (2007) 5.94
Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science (2005) 5.52
Scrapie prion protein contains a phosphatidylinositol glycolipid. Cell (1987) 5.12
The scrapie-associated form of PrP is made from a cell surface precursor that is both protease- and phospholipase-sensitive. J Biol Chem (1991) 4.23
Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform. J Cell Biol (1995) 3.66
N-terminal truncation of the scrapie-associated form of PrP by lysosomal protease(s): implications regarding the site of conversion of PrP to the protease-resistant state. J Virol (1991) 3.55
Molecular assessment of the potential transmissibilities of BSE and scrapie to humans. Nature (1997) 2.80
Evidence for synthesis of scrapie prion proteins in the endocytic pathway. J Biol Chem (1992) 2.67
Prions and their partners in crime. Nature (2006) 2.55
Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrP-res (PrP(Sc)) into contiguous membranes. EMBO J (2002) 2.16
Analyses of frequency of infection, specific infectivity, and prion protein biosynthesis in scrapie-infected neuroblastoma cell clones. J Virol (1988) 1.92
Heterologous PrP molecules interfere with accumulation of protease-resistant PrP in scrapie-infected murine neuroblastoma cells. J Virol (1994) 1.85
Cell-surface engineering with GPI-anchored proteins. FASEB J (1996) 1.59
Intercellular transfer of the cellular prion protein. J Biol Chem (2002) 1.54
PrP(C) expression in the peripheral nervous system is a determinant of prion neuroinvasion. J Gen Virol (2000) 1.26
Glycosylation influences cross-species formation of protease-resistant prion protein. EMBO J (2001) 1.17
Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. Virology (2008) 1.10
Efficient conversion of normal prion protein (PrP) by abnormal hamster PrP is determined by homology at amino acid residue 155. J Virol (2001) 1.00
Purification and partial characterization of the normal cellular homologue of the scrapie agent protein. J Infect Dis (1988) 1.00
Coexpression of wild-type and mutant prion proteins alters their cellular localization and partitioning into detergent-resistant membranes. Traffic (2008) 0.91
Ultrasensitive detection of scrapie prion protein using seeded conversion of recombinant prion protein. Nat Methods (2007) 3.74
Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat Methods (2008) 2.56
Rabbits are not resistant to prion infection. Proc Natl Acad Sci U S A (2012) 1.63
Nonpsychoactive cannabidiol prevents prion accumulation and protects neurons against prion toxicity. J Neurosci (2007) 1.61
Multiple amino acid residues within the rabbit prion protein inhibit formation of its abnormal isoform. J Virol (2003) 1.35
Susceptibilities of nonhuman primates to chronic wasting disease. Emerg Infect Dis (2009) 1.33
Susceptibility of common fibroblast cell lines to transmissible spongiform encephalopathy agents. J Infect Dis (2004) 1.25
Acute formation of protease-resistant prion protein does not always lead to persistent scrapie infection in vitro. J Biol Chem (2004) 1.21
Molecular basis of scrapie strain glycoform variation. J Biol Chem (2002) 1.16
Acute cellular uptake of abnormal prion protein is cell type and scrapie-strain independent. Virology (2008) 1.10
Octapeptide repeat insertions increase the rate of protease-resistant prion protein formation. Protein Sci (2006) 1.07
Prion protein misfolding and disease. Curr Opin Struct Biol (2009) 1.06
Flexible N-terminal region of prion protein influences conformation of protease-resistant prion protein isoforms associated with cross-species scrapie infection in vivo and in vitro. J Biol Chem (2004) 1.01
Comparative profiling of highly enriched 22L and Chandler mouse scrapie prion protein preparations. Proteomics (2010) 0.99
DNA aptamers that bind to PrP(C) and not PrP(Sc) show sequence and structure specificity. Exp Biol Med (Maywood) (2006) 0.98
Endocytosis of prion protein is required for ERK1/2 signaling induced by stress-inducible protein 1. J Neurosci (2008) 0.96
Recombinant prion protein refolded with lipid and RNA has the biochemical hallmarks of a prion but lacks in vivo infectivity. PLoS One (2013) 0.90
Identification and removal of proteins that co-purify with infectious prion protein improves the analysis of its secondary structure. Proteomics (2011) 0.85
Cyclic tetrapyrrole sulfonation, metals, and oligomerization in antiprion activity. Antimicrob Agents Chemother (2007) 0.83
Amyloid formation via supramolecular peptide assemblies. Biochemistry (2007) 0.81
Disinfection and sterilization of prion-contaminated medical instruments. Infect Control Hosp Epidemiol (2010) 0.81
A specific population of abnormal prion protein aggregates is preferentially taken up by cells and disaggregated in a strain-dependent manner. J Virol (2013) 0.79
Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease. J Virol (2013) 0.78
Proteomics analysis of amyloid and nonamyloid prion disease phenotypes reveals both common and divergent mechanisms of neuropathogenesis. J Proteome Res (2014) 0.77
Co-infection with the friend retrovirus and mouse scrapie does not alter prion disease pathogenesis in susceptible mice. PLoS One (2012) 0.76
Proteomics applications in prion biology and structure. Expert Rev Proteomics (2015) 0.76
Correction: The Distribution of Prion Protein Allotypes Differs Between Sporadic and Iatrogenic Creutzfeldt-Jakob Disease Patients. PLoS Pathog (2016) 0.75